Immucell Corp

ICCC

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000811641

SEC filings (opens in a new tab)

No open-market purchases or sales by Immucell Corp insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.4M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Immucell Corp changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of ICCC: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Q2 2021	Change
Holders	28	28	0
Shares	747.0K	784.7K	+37.8K (+5.1%)
Value	$7.20M	$7.45M	+$255.0K (+3.5%)

New holders (1)

Institutions that held Immucell Corp at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ICCC in Q2 2021
Institution	Shares	Value	% of portfolio
Bleichroeder LP	60,607	$576.0K	0.09%

Sold out (1)

Institutions that held Immucell Corp at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ICCC in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Wedge Capital Management L L P	20,384	$197.0K